Quantitative Epstein-Barr Virus Viral Load Monitoring in Pediatric Liver Transplantation

Transplantation Proceedings

Volumn 40, Issue 8, 2008, Pages 2546-2548

  Jang, J Y ^a   Kim, K M ^a   Lee, Y J ^a   Lee, S G ^a   Chi, H S ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; EPSTEIN BARR VIRUS; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT MONITORING; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SURVIVAL RATE; VIRUS INFECTION; VIRUS LOAD;

CHILD, PRESCHOOL; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOSUPPRESSION; INFANT; INFANT, NEWBORN; LIVER DISEASES; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISORDERS; MONITORING, PHYSIOLOGIC; POLYMERASE CHAIN REACTION; RNA, VIRAL; VIRAL LOAD;

EID: 53149114141     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.07.014     Document Type: Article

References (9)

1. Smets F., and Sokal E.M. Epstein-Barr virus-related lymphoproliferation in children after liver transplant: role of immunity, diagnosis, and management. Pediatr Transplant 6 (2002) 280
2. Bakker N.A., van Imhoff G.W., Verschuuren E.A., et al. Presentation and early detection of post-transplant lymphoproliferative disorder after solid organ transplantation. Transpl Int 20 (2007) 207
3. Kullberg-Lindh C., Ascher H., Saalman R., et al. Epstein-Barr viremia levels after pediatric liver transplantation as measured by real-time polymerase chain reaction. Pediatr Transplant 10 (2006) 83
4. Lee T.C., Savoldo B., Rooney C.M., et al. Quantitative EBV viral loads and immunosuppression alterations can decrease PTLD incidence in pediatric liver transplant recipients. Am J Transplant 5 (2005) 2222
5. Patel S., Zuckerman M., and Smith M. Real-time quantitative PCR of Epstein-Barr virus BZLF1 DNA using the LightCycler. J Virol Meth 109 (2003) 227
6. Hwang S., Lee S.G., Lee Y.J., et al. Lessons learned from 1,000 living donor liver transplantations in a single center: how to make living donations safe. Liver Transpl 12 (2006) 920
7. Scheenstra R., Verschuuren E.A., de Haan A., et al. The value of prospective monitoring of Epstein-Barr virus DNA in blood samples of pediatric liver transplant recipients. Transpl Infect Dis 6 (2004) 15
8. Axelrod D.A., Holmes R., Thomas S.E., et al. Limitations of EBV-PCR monitoring to detect EBV associated post-transplant lymphoproliferative disorder. Pediatr Transplant 7 (2003) 223
9. Smets F., Latinne D., Bazin H., et al. Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease. Transplantation 73 (2002) 1603